Instadose Pharma Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Instadose Pharma Corp. generated cash of -$82, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$82.
Cash Flow
| 2018 | -4.15K | 0 | 2.84K |
|---|---|---|---|
| 2021 | -82 | 0 | 0 |
INSD Cash Flow Statement (2019 – 2022)
| 2022 | 2019 | |
|---|---|---|
Cash at beginning of period | 82 | 1.44K |
Operating activities | ||
Net income | -588.71K | -31.25K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
| Deferred income tax benefit | 0 | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | 10.75K | -558 |
Cash generated by operating activities | -82 | -4.15K |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 0 | 0 |
Financing activities | ||
Common Stock Issued | 0 | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | 0 | 2.84K |
Net Change In Cash | -82 | -1.30K |
Cash at end of period | 0 | 132 |
| Data source | Data source |